Skip to Content
MilliporeSigma

Skip To

8.56066

Sigma-Aldrich

H-Tyr(tBu)-2-ClTrt resin

Novabiochem®

Sign Into View Organizational & Contract Pricing

Select a Size

100 μG
671,00 $

671,00 $


Please contact Customer Service for Availability
A recombinant, preservative-free antibody is available for your target. Try ZRB1594

Request a Bulk Order

Select a Size

Change View
100 μG
671,00 $

About This Item

UNSPSC Code:
12352209
NACRES:
NA.22

671,00 $


Please contact Customer Service for Availability
A recombinant, preservative-free antibody is available for your target. Try ZRB1594

Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Level

product line

Novabiochem®

form

beads

reaction suitability

reaction type: Fmoc solid-phase peptide synthesis

manufacturer/tradename

Novabiochem®

application(s)

peptide synthesis

storage temp.

2-8°C

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
HPA042603HPA046339HPA011994
conjugate

unconjugated

conjugate

unconjugated

conjugate

unconjugated

conjugate

unconjugated

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

biological source

rabbit

biological source

rabbit

biological source

rabbit

biological source

rabbit

antibody form

affinity isolated antibody

antibody form

affinity isolated antibody

antibody form

affinity isolated antibody

antibody form

affinity isolated antibody

product line

Prestige Antibodies® Powered by Atlas Antibodies

product line

Prestige Antibodies® Powered by Atlas Antibodies

product line

Prestige Antibodies® Powered by Atlas Antibodies

product line

Prestige Antibodies® Powered by Atlas Antibodies

UniProt accession no.

Q15800

UniProt accession no.

Q9Y316

UniProt accession no.

Q9HCL2

UniProt accession no.

Q99685

General description

Pre-loaded resin for synthesis of protected peptide acids containing a C-terminal tyrosine amino-acid residue by Fmoc SPPS. Cleavage of the protected peptide is effected by treatment with 1% TFA in DCM or 20% TFE in DCM

Associated Protocols and Technical Articles
Cleavage and Deprotection Protocols for Fmoc SPPS

Linkage

Replaces: 04-12-2820

Analysis Note

Color (visual): white to yellow to beige
Appearance of substance (visual): beads
Loading (determined from the substitution of the Fmoc-Leu loaded resin): 0.30 - 0.90 mmol/g
Swelling Volume (in DMF): lot specific result
Identity (of the substitution): passes test
The polymer matrix is copoly (styrene -1% DVB ), 200 - 400 mesh.

Legal Information

Novabiochem is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Francesca Angileri et al.
Biochimica et biophysica acta, 1852(12), 2603-2617 (2015-09-12)
Hereditary tyrosinemia type 1 (HT1) is the most severe inherited metabolic disease of the tyrosine catabolic pathway, with a progressive hepatic and renal injury and a fatal outcome if untreated. Toxic metabolites accumulating in HT1 have been shown to elicit
Maialen Palomino-Alonso et al.
International journal of molecular sciences, 18(11) (2017-10-28)
Olfaction is often deregulated in Alzheimer's disease (AD) patients, and is also impaired in transgenic Tg2576 AD mice, which overexpress the Swedish mutated form of human amyloid precursor protein (APP). However, little is known about the molecular mechanisms that accompany
Mercedes Lachén-Montes et al.
Journal of personalized medicine, 11(6) (2021-07-03)
The most common form of mixed dementia (MixD) is constituted by abnormal protein deposits associated with Alzheimer's disease (AD) that coexist with vascular disease. Although olfactory dysfunction is considered a clinical sign of AD-related dementias, little is known about the
Paz Cartas-Cejudo et al.
Biology of sex differences, 14(1), 5-5 (2023-02-10)
Smell impairment is one of the earliest features in Alzheimer's (AD) and Parkinson's diseases (PD). Due to sex differences exist in terms of smell and olfactory structures as well as in the prevalence and manifestation of both neurological syndromes, we
Peripheral serotonin regulates maternal calcium trafficking in mammary epithelial cells during lactation in mice.
Laporta J, Keil KP, Vezina CM, et al.
PLoS ONE, 9(10), e110190-e110190 (2014)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service